Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?

Neuroscience letters·2000

Same author

[Allogeneic bone marrow transplantation for primary myelofibrosis after splenectomy].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2000

Same author

Abstinence from drink ameliorated cerebral blood flow and vasoreactivity in patients with chronic alcoholism.

The Keio journal of medicine·2000

Same author

Constituents in watercress: inhibitors of histamine release from RBL-2H3 cells induced by antigen stimulation.

Biological & pharmaceutical bulletin·2000

Same author

Requirement of autocrine signaling by bone morphogenetic protein-4 for chondrogenic differentiation of ATDC5 cells.

FEBS letters·2000

Same author

Expression of PDGF-beta receptor, EGF receptor, and receptor adaptor protein Shc in rat osteoblasts during spaceflight.

Molecular and cellular biochemistry·2000

Search research articles

Related Experiment Video

Updated: May 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell

S Kurosawa¹, K Yakushijin, T Yamaguchi

¹Stem Cell Transplantation Division, National Cancer Center Hospital, 5-5-5 Tsukiji, Chuo-ku, Tokyo, Japan.

Bone Marrow Transplantation

|April 9, 2013

Summary

Improvements in allogeneic hematopoietic cell transplantation (allo-HCT) reduced non-relapse mortality (NRM) in acute leukemia patients not in remission. Reductions in graft-versus-host disease (GVHD) and infection-related deaths were key factors.

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Related Experiment Videos

Last Updated: May 12, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Area of Science:

Hematology
Transplantation Immunology
Oncology

Background:

Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes have improved, but data on non-remission cases are limited.
Understanding factors influencing outcomes in non-remission allo-HCT is crucial for patient care.

Purpose of the Study:

To analyze trends in non-relapse mortality (NRM) and causes of death after allo-HCT in acute leukemia patients not in remission.
To evaluate the impact of evolving transplant modalities on allo-HCT outcomes.

Main Methods:

Analysis of a nationwide transplant registry database covering 3308 acute leukemia patients in non-remission.
Comparison of NRM incidence and causes across three consecutive four-year periods (1997-2008).

Main Results:

A significant decrease in NRM was observed in the 2005-2008 period compared to 1997-2000 (HR 0.65).
Overall mortality also significantly decreased in 2005-2008 (HR 0.85).
Reduced deaths from graft-versus-host disease (GVHD) and infection contributed to lower NRM, potentially due to improved HLA matching.

Conclusions:

Effective prevention of transplant-related complications, such as GVHD and infection, is essential for improving survival in non-remission allo-HCT.
Improvements in transplant strategies have positively impacted outcomes for these high-risk patients.